Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SDA1 domain containing 1 pseudogene 2 is classified as a **pseudogene** in humans. Pseudogenes are DNA sequences related to known genes but contain mutations that prevent their expression as functional proteins[3][7][8][10]. SDAD1P2 shares homology with the protein-coding SDA1 domain containing 1 (SDAD1) gene, which is involved in ribosomal subunit biogenesis, but SDAD1P2 itself is not functional and does not encode a protein[3][5][7][9]. As a pseudogene, SDAD1P2 does not serve as a therapeutic target and does not have biological, disease, or drug association information in major scientific resources. **Additional notes:** - **Is_incorrect = true:** The entry “SDA1 domain containing 1 pseudogene 2” is not a valid drug or therapeutic target; it is a pseudogene (nonfunctional gene remnant)[3][5][7][8]. It should not be included in lists of candidate targets for drug development or disease association unless emerging functional evidence is reviewed. - Pseudogenes in general have been studied for possible non-coding functions (such as microRNA sponges or regulatory RNAs), but this is rare and not established for SDAD1P2[6][8][10]. **Summary:** SDAD1P2 is a human pseudogene, not a protein, enzyme, transporter, or receptor, and it has no recognized function, disease association, or druggability. It should not be considered a therapeutic target[3][5][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SDA1 domain containing 1 pseudogene 2 (SDAD1P2).